News & Updates

Show Multimedia Only

AIH linked to higher lymphoma, myeloma risks, but not to extrahepatic malignancy

01 Nov 2025

Patients with autoimmune hepatitis (AIH) do not show an increased risk of overall extrahepatic malignancy compared with controls, but they appear to be at greater risk of lymphoma or myeloma, independent of immunosuppressant use, suggests a study.

AIH linked to higher lymphoma, myeloma risks, but not to extrahepatic malignancy

01 Nov 2025

Mild endoscopic disease activity poses risk for older adults with IBD

31 Oct 2025

For older adults with inflammatory bowel disease (IBD), mild endoscopic activity is linked to adverse IBD-specific and morbidity-related outcomes relative to endoscopic remission, as reported in a retrospective study.

Mild endoscopic disease activity poses risk for older adults with IBD

31 Oct 2025

Original New Drug Application Approvals by US FDA (16-30 September 2025)

31 Oct 2025

New drug applications approved by US FDA as of 16-30 September 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-30 September 2025)

31 Oct 2025

Liver metastasis, tumour size predict recurrence in mRCC after surgery

29 Oct 2025

In patients with synchronous metastatic renal cell carcinoma (mRCC), factors such as liver metastasis, increasing primary tumour size, and elevated preoperative C-reactive protein (CRP) predict the risk of first-year progression following cytoreductive nephrectomy and complete metastasectomy, suggests a recent study.

Liver metastasis, tumour size predict recurrence in mRCC after surgery

29 Oct 2025

Near-normal histology in UC tied to clinical relapse

29 Oct 2025 by

A normal or near-normal histology in ulcerative colitis (UC) is associated with moderate rates of clinical relapse, suggests a study.

Near-normal histology in UC tied to clinical relapse

29 Oct 2025

Margin ablation averts polyp recurrence

28 Oct 2025

Ablation of endoscopic mucosal resection (EMR) margins effectively prevents the recurrence of colorectal polyps at first surveillance colonoscopy, reveals a study.

Margin ablation averts polyp recurrence

28 Oct 2025

Rifaximin works quicker than LFD in IBS symptom management

28 Oct 2025

In the treatment of patients with irritable bowel syndrome (IBS), rifaximin is as good as the low FODMAP diet (LFD), although the drug provides faster symptom relief and is associated with higher adherence, according to a study.

Rifaximin works quicker than LFD in IBS symptom management

28 Oct 2025

What is the most cost-effective CRC screening strategy in Asians?

26 Oct 2025 by

Faecal immunochemical test (FIT) positive result followed by artificial intelligence (AI)–assisted colonoscopy represents the most cost-effective colorectal cancer (CRC) screening strategy in an Asian population, according to a study from the Chinese University of Hong Kong (CUHK).

What is the most cost-effective CRC screening strategy in Asians?

26 Oct 2025

Faecal transplant blocks UTI return

25 Oct 2025 by

Faecal microbiota transplantation has been shown to help resolve recurrent urinary tract infections in a small study.

Faecal transplant blocks UTI return

25 Oct 2025

[Infographics] Expanding roles of semaglutide in CKM syndrome

23 Oct 2025

Semaglutide is a key organ-protective medication for managing cardio-kidney-metabolic (CKM) syndrome. Discover more about positive trial results across seven key components of CKM syndrome, and upcoming data on semaglutide.

[Infographics] Expanding roles of semaglutide in CKM syndrome

23 Oct 2025

News & Updates

Showing Gastroenterology articles

Showing

Specialty:

AIH linked to higher lymphoma, myeloma risks, but not to extrahepatic malignancy

AIH linked to higher lymphoma, myeloma risks, but not to extrahepatic malignancy

Mild endoscopic disease activity poses risk for older adults with IBD

Mild endoscopic disease activity poses risk for older adults with IBD

Original New Drug Application Approvals by US FDA (16-30 September 2025)

Original New Drug Application Approvals by US FDA (16-30 September 2025)

Liver metastasis, tumour size predict recurrence in mRCC after surgery

Liver metastasis, tumour size predict recurrence in mRCC after surgery

Near-normal histology in UC tied to clinical relapse

Near-normal histology in UC tied to clinical relapse

Margin ablation averts polyp recurrence

Margin ablation averts polyp recurrence

Rifaximin works quicker than LFD in IBS symptom management

Rifaximin works quicker than LFD in IBS symptom management

What is the most cost-effective CRC screening strategy in Asians?

What is the most cost-effective CRC screening strategy in Asians?

Faecal transplant blocks UTI return

Faecal transplant blocks UTI return

[Infographics] Expanding roles of semaglutide in CKM syndrome

[Infographics] Expanding roles of semaglutide in CKM syndrome